DNA bindings of a novel anticancer drug, trans-[PtCl2(isopropylamine)(3-picoline)], and kinetic competition of purine bases with protein residues in the bifunctional substitutions: a theoretical DFT study

2009 ◽  
Vol 123 (5-6) ◽  
pp. 455-468 ◽  
Author(s):  
Yan Gao ◽  
Lixin Zhou
Keyword(s):  
Anticancer Drug ◽  
Dft Study ◽  
Protein Residues ◽  
Purine Bases

A DFT study of the degradation mechanism of anticancer drug carmustine in an aqueous medium

2019 ◽  
Vol 30 (4) ◽  
pp. 1315-1321 ◽  
Author(s):  
Saba Hadidi ◽  
Farshad Shiri ◽  
Mohammadsaleh Norouzibazaz
Keyword(s):  
Aqueous Medium ◽  
Anticancer Drug ◽  
Degradation Mechanism ◽  
Dft Study

scholarly journals DFT study of [Pt(Cl)2L] complex (L = rubeanic acid) and its derived compounds with DNA purine bases

2020 ◽  
Vol 530 ◽  
pp. 110646 ◽  
Author(s):  
Amit Kumar ◽  
Gianluca Gatto ◽  
Francesco Delogu ◽  
Luca Pilia
Keyword(s):  
Dft Study ◽  
Purine Bases ◽  
Rubeanic Acid ◽  
Dna Purine Bases

Theoretical Study of Non-Bonded Interaction between Anticancer Drug Fludara and (2S,3R,4S,5S)-2-(Hydroxymethyl)-3,5-dimethyloxolane-3,4-diol: A DFT Study

2021 ◽  
Vol 95 (1) ◽  
pp. 127-138
Author(s):  
Masoome Sheikhi ◽  
Siyamak Shahab ◽  
Shamsa Sharifi ◽  
Evgeny Kvasyuk ◽  
Mehrnoosh Khaleghian
Keyword(s):  
Anticancer Drug ◽  
Theoretical Study ◽  
Dft Study

A DFT study of reactions of Ru(III) anticancer drug KP1019 with 8-oxoguanine and 8-oxoadenine

2020 ◽  
Vol 31 (5) ◽  
pp. 2087-2092
Author(s):  
Pramod Kumar Shah ◽  
P. K. Shukla
Keyword(s):  
Anticancer Drug ◽  
Dft Study
Sign in / Sign up

Export Citation Format

Share Document